Deteriorating Free Cash FlowRecently negative free cash flow weakens internal funding for capex, working capital needs, and shareholder returns. If persistent, this forces reliance on external financing or reduces strategic flexibility to invest in process upgrades and new product development, harming long-term growth.
Sharp Revenue DeclineA ~38.6% revenue contraction signals loss of volume or demand and erodes operating leverage. Sustained top-line weakness limits ability to cover fixed costs, compresses margins, and makes it harder to fund customer development or R&D, threatening medium-term competitive positioning.
Margin Compression And Falling ROECompressing operating margins and declining ROE indicate reduced efficiency and profitability on invested capital. Over months, this undermines cash generation and return profiles, signaling a need for cost control, pricing adjustments, or higher-value product mix to restore sustainable returns.